The government recently loosened medical marijuana rules. Experts separate fact from fiction about the drug’s safety and ...

After breast cancer treatment, Nancy Mason was looking for ways to feel stronger again. She found that support through Atrium ...

Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

In a sweeping analysis of more than 400,000 Reddit posts, researchers have revealed some little-known GLP-1 side effects. GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and ...

A University of Pennsylvania analysis of over 400,000 posts from people taking GLP-1s found mentions of irregular periods, fatigue, chills, and hot flashes. A new study found Reddit users posting ...

With the rapid introduction of novel breast cancer therapies, recognizing and managing side effects is essential to maintain adherence and improve outcomes. As novel oral endocrine therapies and ...

As we move into the warmer weather, a well-known gay doctor has issued a reminder to people who are taking DoxyPEP. DoxyPEP is a 200mg dose of the antibiotic Doxycycline. If taken within 72 hours of a ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Neal Browning, one of the first people to test the COVID-19 Moderna ...

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...